Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.

Journal of virology - 1 Jun 2003

zur Megede Jan, Otten Gillis R, Doe Barbara, Liu Hong, Leung Louisa, Ulmer Jeffrey B, Donnelly John J, Barnett Susan W

Abstract excerpt

Control of the worldwide AIDS pandemic may require not only preventive but also therapeutic immunization strategies. To meet this challenge, the next generation of human immunodeficiency virus type 1 (HIV-1) vaccines must stimulate broad and durable cellular immune responses to multiple HIV antigens. Results of both natural history studies and virus challenge studies with macaques indicate that responses to both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Products, gag

Share to HIV Antibodies

Share to HIV Antigens

Share to Immunization

Share to Mice, Inbred C3H

Share to Vaccines, DNA

Source

Open in PubMed Open full text

Identifiers

PMID: 12743276
DOI: 10.1128/jvi.77.11.6197-6207.2003
PMCID: PMC154993

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.PMID 12743276Read ↗

Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag GeneSemantic proximity Read ↗

Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle.Semantic proximity Read ↗

Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected AdultsSemantic proximity Read ↗

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesSemantic proximity Read ↗

Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins.Semantic proximity Read ↗

Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman PrimatesSemantic proximity Read ↗

Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic ImmunizationSemantic proximity Read ↗

Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaquesSemantic proximity Read ↗

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA VaccinesSemantic proximity Read ↗

Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaquesSemantic proximity Read ↗

Genetic engineering of a modified herpes simplex virus 1 vaccine vector.Semantic proximity Read ↗

Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.